Standout Papers

IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade 2016 2026 2019 2022 2.3k
  1. IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade (2017)
    Mark Ayers, Jared Lunceford et al. Journal of Clinical Investigation
  2. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial (2016)
    Tanguy Y. Seiwert, Barbara Burtness et al. The Lancet Oncology
  3. Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study (2016)
    Rita Nanda, Laura Q.M. Chow et al. Journal of Clinical Oncology
  4. Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study (2017)
    Joshua Bauml, Tanguy Y. Seiwert et al. Journal of Clinical Oncology
  5. PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer (2017)
    Jennifer H. Yearley, Christopher J. Gibson et al. Clinical Cancer Research
  6. Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012 (2018)
    Ranee Mehra, Tanguy Y. Seiwert et al. British Journal of Cancer
  7. Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study (2017)
    Chiun Hsu, Se‐Hoon Lee et al. Journal of Clinical Oncology

Immediate Impact

6 by Nobel laureates 8 from Science/Nature 96 standout
Sub-graph 1 of 18

Citing Papers

Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
A pan-cancer analysis of the microbiome in metastatic cancer
2024 Standout

Works of Jonathan D. Cheng being referenced

IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
2017 Standout
Extended Structure–Activity Relationship and Pharmacokinetic Investigation of (4-Quinolinoyl)glycyl-2-cyanopyrrolidine Inhibitors of Fibroblast Activation Protein (FAP)
2014

Author Peers

Author Last Decade Papers Cites
Jonathan D. Cheng 8648 3232 2279 2926 112 11.7k
Laura Q.M. Chow 8861 4544 1279 2951 156 12.1k
Hagop Youssoufian 4155 3104 1778 760 172 12.8k
Alessandro Lugli 5939 1685 1710 1387 210 9.5k
Tanguy Y. Seiwert 6863 3681 1876 2456 226 10.8k
Mark E. Prince 4622 1736 2643 947 227 9.6k
Antonio Jimeno 3392 1378 573 1020 166 7.0k
Chad Tang 2719 1891 1222 1595 183 7.0k
Christophe Le Tourneau 4735 2202 1286 1226 320 8.4k
Scott V. Bratman 3201 2671 793 1477 170 8.2k
P Pouillart 5015 1662 1179 1344 259 9.0k

All Works

Loading papers...

Rankless by CCL
2026